Canceramrconsortium logo

Cancer & AMR Consortium

Addressing the need for data to accelerate advocacy, policy and innovation

An Increased Threat of Drug-Resistant Infection

Many professionals assume that cancer patients in treatment are at a higher risk of developing a drug-resistant infection. Unfortunately, there has been very little research on it to date.

quote icon For many cancer patients who die from this awful disease, their tumors aren’t solely responsible. In many instances, superbugs sicken these patients, who can’t fight off resistant infections due to weakened immune systems — even with the help of antibiotics.1 quote icon
- Cynthia L. Sears and Fyza Yusuf Shaikh


  1. https://​www​.bal​ti​more​sun​.com/​o​p​i​n​i​o​n​/​o​p​-​e​d​/​b​s​-​e​d​-​o​p​-​0​9​1​3​-​s​u​p​e​r​b​u​g​s​-​c​a​n​c​e​r​-​m​o​o​n​s​h​o​t​-​2​0​2​2​0​9​1​2​-​d​n​p​v​3​o​j​i​4​f​a​4​z​n​c​a​p​7​n​y​a​i​m​j​m​u​-​s​t​o​r​y​.html, accessed 11/20/2023
  2. Gupta, V. Burden of Antimicrobial Resistance in Hospitalized Patients with Cancer: A Multicenter Analysis. Poster presented at: ASM-ESCMID 2023 Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance (ASM-ESCMID) 19 – 22 September 2023 ï Boston, MA USA.

Share Your Story and Become an Antimicrobial Resistance Fighter